Print Friendly

All E-Alerts

E-Alerts

FDA Warns of Life-Threatening Blood Clots With Use of High-Dose Tofacitinib (XELJANZ, XELJANZ XR) (March 6, 2019)
FDA Announces Recalls of Certain Valsartan-Containing Medications Because of Cancer-Causing Contaminant (July 18, 2018)
FDA Announces Withdrawal of Multiple Sclerosis Drug From the U.S. Market Because of Serious Safety Concerns (March 16, 2018)
FDA Warns of Risk of Serious Liver Injury and Death in Certain Patients if Obeticholic Acid is Incorrectly Dosed (September 27, 2017)
Food and Drug Administration Warns of Serious Pancreatitis With Use of Eluxadoline (Viberzi) (March 23, 2017)
Food and Drug Administration Warns of Toxic Belladonna Levels in Infant Teething Products (February 3, 2017)
Food and Drug Administration Warns of Hepatitis B Reactivation With Hepatitis C Drugs (October 7, 2016)
Food and Drug Administration Evaluating Safety of Fluconazole (Diflucan) in Pregnancy (May 6, 2016)
Food and Drug Administration Warns of Heart Failure With Diabetes Drugs (April 13, 2016)
Food and Drug Administration Warns of Severe Joint Pain With Diabetes Drugs (September 9, 2015)

3 of 11